News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Alta Partners Announces $25 Million Investment in Anesiva, Inc. (ANSV)


12/17/2007 12:15:28 PM

SAN FRANCISCO--(BUSINESS WIRE)--Alta Partners, a leading life sciences venture capital firm, today announced a $25 million investment in Anesiva, (Nasdaq:ANSV) a late-stage biopharmaceutical company focused on the development and commercialization of novel therapeutic treatments for pain management. Alta Partners was the lead investor in a common stock offering valued at a total of approximately $45 million. Alta Partners has been an investor in Anesiva (formerly “Corgentech”) since November of 2000.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES